Ameri Holdings Inc (AMRH) 시세

Just Wow! I've taken some round trips before but never that far that fast. Yesterday Tikun Olam's value flexed it's muscle. I think the mention of a reverse split scared everyone today. I don't think there will even be a reverse split unless absolutely necessary for their Nasdaq eligibility. With the tiny float I believe yesterday's high was just a warm up of what's to come.

* * $AMRH Video Chart 12-28-2020 * *

Link to Video - click here to watch the technical chart video

$2.30 nice

Vote to complete merger is on 12/23.20. Tikun Olam has potential to be as good or better than than GW Pharma.

$AMRH Super Play. This is a hot low float driving stock play for Monday! Could see. 200% Gain. Second High watch. $WORX see two day volume gains. Large Momentum moving. Could also 200% Gain. Both Strong Buys.

Agree
This is a great set up. Will be accumulating into merger. MJ and CBD are heating up with the transition in the White House. The perfect storm for this small float.
Good Luck

AMERI Holdings Declares Form S-4 Related To Co.'s Tender Deal With Jay Pharma To Be Effective low float 10 bagger.

NEWS: $AMRH Are These On Your List Of Penny Stocks To Buy Or Sell In October?

Which Penny Stocks Are On Your List? When it comes to penny stocks , you should be prepared for a road of volatility. These stocks under $5 can easily move 50% in any direction in a single day. Trading penny stocks could be difficult if you don’t take the time for it thou...

In case you are interested AMRH - Are These On Your List Of Penny Stocks To Buy Or Sell In October?

Pr pm or am?....

Added on my volume scanner...

$AMRH | #AmeriHoldings Bullish Setup



Ameri Holdings , Inc. is a technology services company, which specializes in systems, applications, and products (SAP) cloud, digital, and enterprise services. It offers technology consulting; business intelligence; cloud services; application development, integration, and maintenance; implementation services; infrastructure services; and independent validation services. The company was founded by Srinidhi Devanur in February 1994 and is headquartered in Suwanee, GA.

July 1, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) ("Ameri" or the "Company"), announced that the Company is continuing to work through the regulatory review process towards finalizing the proposed amalgamation transaction with Jay Pharma, Inc. ("Jay Pharma"),

2.7 Mill Float

3 Mill o/s Pending Deal Closing ~>


Pending Transaction With Jay Pharma Inc. ATLANTA , July 1, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) ("Ameri" or the "Company"), announced that the Company is continuing to work through the regulatory review process towards finalizing the proposed amalgamation transaction with Jay Pharma, Inc. ("Jay Pharma"),

News: $AMRH Ameri Holdings Provides Update On Pending Transaction With Jay Pharma Inc.

ATLANTA , July 1, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) ("Ameri" or the "Company"), announced that the Company is continuing to work through the regulatory review process towards finalizing the proposed amalgamation transaction with Jay Pharma, Inc. ("Jay Pharma"),...

In case you are interested AMRH - Ameri Holdings Provides Update On Pending Transaction With Jay Pharma Inc.

News ??

LOL...got us.
Congratzz on who sold on pop.
Holding a Bag here still....

Hawk

Pump and dump

Next one is $RLBY

This was all a pump and dump

Same people involved in AMRH are also involved with RLBY (next pump)

Buy RLBY for the next PUMP!

* * $AMRH Video Chart 06-02-2020 * *

Link to Video - click here to watch the technical chart video

Well the question is would it even stay above 3??

Retrace on spike.
Watch for turn.

Hawk

Dosent matter i bought it and started going down, not sure if this will go up again unless i sell lol

Vol. 43 M already.

AMERI Holdings Amalgamation Partner Jay Pharma Reports IRB Approval For Testing Proprietary CBD Formulation In Brain Cancer
June 02 2020 - 09:00AM
PR Newswire (US) Print
ATLANTA, June 2, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) (the "Company"), today announced that its proposed amalgamation partner Jay Pharma Inc. ("Jay Pharma") received institutional review board ("IRB") approval by Rabin Medical Center in Petah Tikva, Israel for a Phase I/II clinical trial investigating Jay Pharma's proprietary cannabidiol ("CBD") formulation for the treatment of glioblastoma multiforme ("GBM"), a rare and aggressive form of brain cancer. This open-label, two-arm, randomized, prospective study is scheduled to commence following final approval from the Israel Ministry of Health, which is expected this summer.

Wild

Actually, with this float, a well orchestrated, well compensated, P and D could move this quite a bit. They might try it, ethics has never been one of their corporate qualities...

Wonder if this road to nowhere POS is trying to resurrect. Could move, with a big budget P and D...

10 bagger

You should post on RLBY board.

He is a fraudster who belongs in jail. His fund was closed down because he was a terrible investor.

Ladies and Gentlemen,

Please check this out:

Jeffrey Eberwein's fraud has been exposed and he has been sued!

https://ws.onehub.com/files/awm81zww

Beware of your investment!!

News is what ??

Hawk

Action EOD and AH....bidder at Table finally ?!

Hawk

Halted for volatility, for some reason.

On the one hand AMRH CFO very weak on the other hand Jay CEO very inspiring.

I was missing some facts like
- whats the compensation for IT business
- what happens with liabilities, receivables etc
- actual Revenue & Profit of Jay Pharma
- dividend to shareholders

and a lot more.

No transparency for now.... hopefully authorities and shareholders will not approve this status.
For now I feel the old shareholders are hornswoggled by fraudsters.

KS

AH...$1.86.
Someone like the call?!

Hawk

Anyone dial in ??

That is how the company ads share holder value what a bunch of A-holes.

Basically, spin all value out of the shell, screw commons, dump shell on POS company, live to scam again. Not their first rodeo...

CC announced....yep, explain this to us...

AMERI Holdings, Inc. (NASDAQ: AMRH) (“Ameri”), will host a conference call and webcast at 4:15 p.m. ET on Thursday, January 16, 2020, to discuss its entry into an amalgamation agreement (the “transaction”) announced today whereby the shareholders of Jay Pharma will become the majority holders of Ameri’s outstanding stock.

Same folks involved with $RLBY

It seems like it’s all the same; folks from India running a pump and dump shell.

The founders of this shell is also running the same shell $RLBY

Do the research

So, basically, scam commons, spin out anything of value, leave the shell...sounds like a typical POS OTC scam rather than an actual company, not surprised, but pathetically sad all the same...

I guess this means they will never be Google certified!

So much for the IT part.....

In connection with the Amalgamation, Ameri will spin-off its existing IT services business to a private entity founded by Ameri management in partnership with Ameri’s current Series A Preferred Equity Holders (the “Spin-Off,” and collectively, with the Amalgamation, the “Transactions”). The Transactions are expected to close in the first half of 2020, subject to Ameri shareholder approval, approval of the Nasdaq Stock Market, and other customary closing conditions.

AMERI Holdings, Inc. (NASDAQ: AMRH) (“Ameri”) today announced it entered into an amalgamation agreement (the “Amalgamation Agreement”) with Jay Pharma Inc. (“Jay Pharma”), a Canadian company dedicated to developing innovative, evidence-based cannabinoid products and combination therapies to address unmet needs in cancer care, pursuant to which the shareholders of Jay Pharma will become the majority holders of Ameri’s outstanding stock by way of an amalgamation (the “Amalgamation”). In connection with the Amalgamation, Ameri will spin-off its existing IT services business to a private entity founded by Ameri management in partnership with Ameri’s current Series A Preferred Equity Holders (the “Spin-Off,” and collectively, with the Amalgamation, the “Transactions”). The Transactions are expected to close in the first half of 2020, subject to Ameri shareholder approval, approval of the Nasdaq Stock Market, and other customary closing conditions.
“We are excited about the Jay Pharma business and believe that it is a great opportunity that will maximize shareholder value,” said Dev Nidhi, Executive Chairman of Ameri.

On a pro forma basis and based upon the number of shares of Ameri common stock to be issued in the Amalgamation, current Ameri shareholders will own approximately 16% of the combined company and current Jay Pharma shareholders will own approximately 84% of the combined company. The Boards of Directors of both Ameri and Jay Pharma have unanimously approved the transaction.

Jay Pharma is primarily focused on developing over-the-counter cannabinoid-based palliative and wellness products to address the side effects of cancer and cancer treatment, including skin reactions, pain, nausea, and anxiety. Jay Pharma holds the exclusive rights to Israel-based Tikun Olam Ltd.’s (“Tikun Olam”) proprietary cannabinoid genetics and data for oncology, including for the development of over-the-counter and pharmaceutical products. Tikun Olam has amassed one of the world’s largest patient treatment databases in the field of medical cannabis, with over 20,000 patient records noting strains used and symptoms treated. Use of Tikun Olam strains were analyzed in 2,970 cancer patients seeking assistance with sleep problems, pain, nausea, and lack of appetite (Bar-lev Schleider, Eur J Intern Med, 2018); treatment was found to be a well-tolerated, effective, and safe option to help patients cope with the malignancy related symptoms. Jay Pharma plans to bring leading oncology clinicians and researchers, together with academic and industry partners to enhance clinically proven products to patients. In addition, Jay Pharma has an experienced management team led by Dave Johnson who will assume the Chairman & CEO role upon the closing of the Transactions.

Interest at the Table ?!

Hmmm...

Going to see our morning buyer again today ?

Hawk